Back to WiM Massachusetts Chapter Affiliated Members
Deputy Director Quality Analytical Expert
Contact information may be available to logged in members.
Elena Smith, PhD, is Quality Analytical Expert at Sanofi and provides Quality expert support to the product international launches. Dr Smith joined Protein Sciences Corporation (acquired by Sanofi in 2017) in 2013 and led Quality Control for the commercialization of the new product, world's first recombinant Influenza vaccine, with several seasons of product scale-up on the market. Dr. Smith obtained her Ph.D. in Molecular Biology on HIV antivirals following completion of postdoctoral training on Molecular Pharmacology at U.S. National Institutes of Health. Dr. Smith focuses her industrial operations interests on quality strategy for new products, standards, tech transfer, manufacturing process, and microbiological control of manufacturing sites. Dr Smith is a lead of subgroup for early availability of reagents at WHO Pandemic SWITCH Potency Assay Working Group contributing to WHO operation plan for Pandemic Influenza Vaccine Response.
Connecticut, Massachusetts, New York, Western Pennsylvania
Continuous Improvement, Production, Quality Control